These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4090586)

  • 1. [Myocardial hypertrophy: regression in hypertrophic cardiomyopathies?].
    Kuhn H
    Z Kardiol; 1985; 74 Suppl 7():179-85. PubMed ID: 4090586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic long-term results after medical and surgical therapy of hypertrophic cardiomyopathies.
    Lösse B; Loogen F; Schulte HD
    Z Kardiol; 1987; 76 Suppl 3():119-30. PubMed ID: 3433864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial biopsy in patients with hypertrophic cardiomyopathy: correlations between morphologic and clinical parameters and development of myocardial hypertrophy under medical therapy.
    Kunkel B; Schneider M; Eisenmenger A; Bergmann B; Hopf R; Kaltenbach M
    Z Kardiol; 1987; 76 Suppl 3():33-8. PubMed ID: 2963449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of wall thickness (by echocardiography and autopsy) in the diagnosis of heart hypertrophy].
    Staiger J; Drexler H; Dickhuth HH; Keul J
    Pathologe; 1988 May; 9(3):158-63. PubMed ID: 3405979
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biventriculographic and clinicopathologic evaluation of apical hypertrophy: with reference to asymmetrical septal hypertrophy with hypertension].
    Genda A; Taga K; Nakayama A; Nunoda S; Horita Y; Sugihara N; Takeda R
    J Cardiogr; 1985 Jun; 15(2):327-38. PubMed ID: 4093618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of hypertrophy in obstructive and non-obstructive types of hypertrophic cardiomyopathy.
    Gregor P; Widimský P; Cervenka V; Sládková T; Vísek V
    Cor Vasa; 1984; 26(4):275-80. PubMed ID: 6541554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Noninvasive and invasive study procedures in hypertrophic cardiomyopathy].
    Sheikhzadeh A; Stierle U; Diederich KW
    Herz; 1985 Apr; 10(2):59-71. PubMed ID: 4039292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reliability and limitation of various diagnostic methods including nuclear medicine in myocardial disease (author's transl)].
    Tokuyasu Y; Kusakabe K; Yamazaki T; Tazaki E; Sekiguchi M; Hiroe M; Morimoto S; Fujioka T; Nakamura K; Hirosawa K
    J Cardiogr; 1981 Dec; 11(4):1113-25. PubMed ID: 7201492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Regional right ventricular hypertrophy in hypertrophic cardiomyopathy and hypertension].
    Seo T; Yokota Y; Kumaki T; Takarada A; Kubo M; Kaku K; Toh S; Fukuzaki H
    J Cardiogr; 1985 Jun; 15(2):339-46. PubMed ID: 4093619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypertrophic cardiomyopathy with dilatation of the left ventricle and congestive heart failure: comparison with postmyocarditis cardiomegaly and hypertensive heart failure].
    Kawanishi H; Yokota Y; Hayakawa M; Kaku K; Kumaki T; Matsumoto K; Fujitani K; Ito Y; Inoh T; Fukuzaki H
    J Cardiogr; 1983 Sep; 13(3):537-50. PubMed ID: 6235295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Echocardiographic parameters in hypertrophic cardiomyopathy during verapamil treatment (author's transl].
    Lemke R; Hopf R; Kober G; Kaltenbach M
    Z Kardiol; 1980 Oct; 69(10):661-8. PubMed ID: 7192909
    [No Abstract]   [Full Text] [Related]  

  • 12. [Regression of heart hypertrophy. Criteria of regression from the viewpoint of the clinician].
    Just H; Holubarsch C; Kasper W; Wollschläger H; Friedburg M
    Z Kardiol; 1985; 74 Suppl 7():127-34. PubMed ID: 2936014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMG CoA reductase inhibition and left ventricular mass in hypertrophic cardiomyopathy: a randomized placebo-controlled pilot study.
    Bauersachs J; Störk S; Kung M; Waller C; Fidler F; Hoyer C; Frantz S; Weidemann F; Ertl G; Angermann CE
    Eur J Clin Invest; 2007 Nov; 37(11):852-9. PubMed ID: 17973781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term treatment of hypertrophic cardiomyopathy with verapamil or propranolol in matched pairs of patients: results of a multicenter study.
    Kober G; Hopf R; Biamino G; Bubenheimer P; Förster K; Kuck KH; Hanrath P; von Olshausen KE; Schlepper M; Kaltenbach M
    Z Kardiol; 1987; 76 Suppl 3():113-8. PubMed ID: 3324526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypertrophic cardiomyopathy with ventricular septal hypertrophy localized to the apical region of the left ventricle (apical ASH)].
    Koga Y; Takahashi H; Ifuku M; Itaya M; Adachi K; Toshima H
    J Cardiogr; 1984 Aug; 14(2):301-10. PubMed ID: 6543446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current therapeutic principles as well as new therapeutic aspects of idiopathic hypertrophic subaortic stenosis. II. Pathophysiology, natural course and diagnosis].
    Hutschenreiter W; Duck HJ; Herbst M; Trenckmann H; Günther K
    Z Gesamte Inn Med; 1980 Feb; 35(4):149-55. PubMed ID: 6996357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relaxation and regional myocardial stiffness in obstructive hypertrophic cardiopathy patients: effect of verapamil].
    Bonandi L; Hess OM; Grimm J; Krayenbühl HP
    G Ital Cardiol; 1984 Feb; 14(2):77-84. PubMed ID: 6538857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical aspects, course and prognosis of various forms of hypertrophic cardiomyopathy].
    Kuhn H; Gietzen F; Mercier J; Lösse B; Köhler E; Schulte HD; Bircks W; Loogen F
    Z Kardiol; 1983 Feb; 72(2):83-98. PubMed ID: 6221476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypertrophic obstructive cardiomyopathy: spontaneous course in comparison to long-term therapy with propranolol and verapamil].
    Haberer T; Hess OM; Jenni R; Krayenbühl HP
    Z Kardiol; 1983 Sep; 72(9):487-93. PubMed ID: 6415946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relation of electrocardiographic features and distribution of hypertrophy in hypertrophic non-obstructive cardiomyopathy during childhood].
    Kamiya Y; Oonaka M; Itoi T; Hamaoka K; Onouchi Z
    J Cardiol; 1994; 24(2):91-106. PubMed ID: 8164151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.